Cystic Fibrosis Market 2015-2022 - Global Strategic Business Report 2017 - FDA Approves Vertex's ORKAMBI - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cystic Fibrosis - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Cystic Fibrosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research.

The report profiles 56 companies, including many key and niche players such as:

  • Advanced Inhalation Therapies (AIT) Ltd. (Israel)
  • Alaxia SAS (France)
  • AlgiPharma AS (Norway)
  • Anthera Pharmaceuticals Inc. (USA)
  • Arch BioPartners (Canada)
  • Celtaxsys Inc. (USA)
  • Concert Pharmaceuticals Inc. (USA)
  • Corbus Pharmaceuticals Holdings Inc.(USA)
  • CURx Pharmaceuticals (USA)
  • Nivalis Therapeutics Inc. (USA)
  • NovaBiotics Ltd. (UK)
  • Parion Sciences Inc. (USA)
  • Pharmaxis Ltd (Australia)
  • PTC Therapeutics Inc. (USA)
  • Pulmatrix Inc. (USA)
  • AbbVie Inc. (USA)
  • Galapagos NV (Belgium)
  • Genentech Inc. (USA)
  • Gilead Sciences Inc. (USA)
  • Novartis AG (Switzerland)
  • Vertex Pharmaceuticals (USA)

Key Topics Covered:

1. Market Overview

2. Research In Cystic Fibrosis Space

3. Disease Overview

4. Cystic Fibrosis Treatment: An Overview

5. Clinical Studies

6. Product Launches/Approvals

7. Recent Industry Activity

8. Select Clinical-Stage Players

9. Focus On Select Global Players

10. Global Market Perspective

Total Companies Profiled: 56 (including Divisions/Subsidiaries 58)

- The United States (30)

- Canada (4)

- Europe (20)

- France (2)

- Germany (2)

- The United Kingdom (3)

- Italy (2)

- Rest of Europe (11)

- Asia-Pacific (Excluding Japan) (1)

- Middle East (3)

For more information about this report visit http://www.researchandmarkets.com/research/nzbg59/cystic_fibrosis.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs